Recent news
and insights
Survey to evaluate stress among healthcare professionals during the COVID-19 pandemic
Your help and input please: A survey on stress among healthcare professionals during the COVID-19 pandemic, by Dr. Fotios Loupakis and Dr. Camilla Gesi
-
HCC Experts Round Table examines the impact of the IMbrave150 trial on evolving standards of care for advanced hepatocellular carcinoma (Americas and EU) GalleryHCC Experts Round Table examines the impact of the IMbrave150 trial on evolving standards of care for advanced hepatocellular carcinoma (Americas and EU)
HCC Experts Round Table examines the impact of the IMbrave150 trial on evolving standards of care for advanced hepatocellular carcinoma (Americas and EU)
Watch the meeting summary and download slides
Covid-19: implications for medical oncologists
A valuable and personal perspective from Italy by Dr. Fotios Loupakis
Experts Forum on DDR and PARP inhibition in Tokyo and Singapore, January 2020
Experts Forum on DDR and PARP inhibition in Tokyo and Singapore
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
A variety of topics are covered including, overview of gene fusions and role as oncogenic drivers, detection approaches available, NTRK family and NTRK gene fusions...
The role of PARP inhibition in clinical practice
Understand why, where and how PARP inhibitors work in clinical practice, and look into the future of targeting DDR with this interactive, free to access e-learning course.
The CONNECTs News
-
NTRK CONNECT Update from ESMO 2020
-
GI Nurses CONNECT Update from ESMO 2020
-
NET CONNECT Update from ESMO 2020
-
HCC CONNECT Update from ILCA and ESMO 2020
-
GU CONNECT Update from ESMO 2020
-
GI CONNECT Update from ESMO 2020
-
GU Nurses CONNECT Update from ASCO 2020
-
The Latest in T-cell Lymphoma
-
GU Nurses CONNECT Update from ASCO 2020
-
Molecular subtypes that exist in paediatric and adult sarcomas. This includes a spotlight on the potential indicators that may hint at the presence of NTRK gene fusions